We are live on ! Find out more
MESO

Mesoblast

68 hedge funds and large institutions have $58.9M invested in Mesoblast in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

480% more call options, than puts

Call options by funds: $22.4M | Put options by funds: $3.87M

55% more capital invested

Capital invested by funds: $37.9M → $58.9M (+$21M)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

0.14% more ownership

Funds ownership: 2.72%2.86% (+0.14%)

6% less funds holding

Funds holding: 7268 (-4)

24% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 17

Holders
68
Holders Change
-4
Holders Change %
-5.56%
% of All Funds
0.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
23
Reduced
18
Closed
17
Calls
$22.4M
Puts
$3.87M
Net Calls
+$18.6M
Net Calls Change
+$16.9M

MESO Hedge Fund Activity: Q3 2025 in Review

68 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2025, worth a combined $58.9M — up 55% from $37.9M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of MESO and 13 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 23 added.

The largest buyer was Legal & General Group, opening a new position worth an estimated $9.53M. The largest seller was BlackRock, cutting an estimated $1.7M.

  • 68 institutional investors held Mesoblast (MESO) as of Q3 2025, down from 72 in Q2 2025.
  • Funds reported $58.9M of Mesoblast stock for Q3 2025, up 55% quarter-over-quarter.
  • 13 funds opened new Mesoblast positions in Q3 2025 and 17 closed out, a net change of -4 holders.
  • The largest Mesoblast buyer in Q3 2025 was Legal & General Group, an estimated $9.53M added.
  • The largest Mesoblast seller in Q3 2025 was BlackRock, an estimated $1.7M sold.

Based on aggregated 13F filings for Q3 2025.